Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Jinglin Zhong"'
Autor:
Qianying Wang, Baojuan Zou, Xiaoya Wei, Hongrong Lin, Changmiao Pang, Lei Wang, Jinglin Zhong, Huamu Chen, Xuefei Gao, Min Li, Albert C. M. Ong, Zhihui Yue, Liangzhong Sun
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Background: Nephronophthisis (NPH) is the most common genetic cause of end-stage renal disease (ESRD) in childhood, and NPHP1 is the major pathogenic gene. Cyst formation at the corticomedullary junction is a pathological feature of NPH, but the mech
Externí odkaz:
https://doaj.org/article/49e016d498484747a7c8bbfe8c06eed1
Publikováno v:
Frontiers in Environmental Science, Vol 10 (2022)
Residents’ satisfaction with post-disaster reconstruction in earthquake-stricken areas directly affects their quality of life, which cannot be ignored in post-disaster reconstruction. More than 10 years after the Wenchuan earthquake, we took ten ra
Externí odkaz:
https://doaj.org/article/29044527b3d54f819ab22dc113494666
Publikováno v:
Frontiers in Environmental Science, Vol 10 (2022)
Earthquake is one of the most serious natural disasters. Taking scientific and reasonable earthquake preparedness measures can effectively reduce casualties and economic losses caused by earthquakes. It is important to understand how residents choose
Externí odkaz:
https://doaj.org/article/416976e1ad814799a8da7d3f6445c9bf
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Earthquakes occur frequently in rural areas of Sichuan, China, causing huge damage and high mortality. The built environment plays a significant role in providing residents with safe and resilient settlements in such areas. There is yet little resear
Externí odkaz:
https://doaj.org/article/a87473ec490e49c8a11f70269663ff22
Autor:
Ronald van Vollenhoven, Cameron Helt, Vipin Arora, Jinglin Zhong, Ana Pinto Correia, Inma de la Torre, David Muram
Publikováno v:
Rheumatology and Therapy, Vol 5, Iss 2, Pp 525-536 (2018)
Abstract Introduction This study assessed if concomitant use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib in rheumatoid arthritis (RA) patients. M
Externí odkaz:
https://doaj.org/article/4274182da21548f18f5fc1f74c1efdee
Autor:
Yibin Ao, Yunhong Liu, Liyao Tan, Ling Tan, Maoqiu Zhang, Qiqi Feng, Jinglin Zhong, Yan Wang, Liang Zhao, Igor Martek
Publikováno v:
Buildings, Vol 11, Iss 12, p 616 (2021)
With the popularization and rise in BIM technology usage, BIM education for undergraduate students in architecture, engineering, and construction (AEC) related disciplines has emerged as a priority. This study assesses the BIM learning outcomes of st
Externí odkaz:
https://doaj.org/article/11e75ede6c7f4ce7835ff4ca63d686db
Publikováno v:
Energies, Vol 14, Iss 21, p 7449 (2021)
In order to realize the intelligent management of a power materials warehouse, the Internet of Things based on wireless sensor networks (WSNs) is a promising effective solution. Considering the limited battery capacity of sensor nodes, the optimizati
Externí odkaz:
https://doaj.org/article/922ddb0b4394430b8937559a030c75fc
Autor:
George Han, Daniel Marnell, Fabio P. Nunes, Orin Goldblum, Amy M. DeLozier, Eric L. Simpson, Emanual Michael Maverakis, Jonathan Janes, Robinette Angle, Emma Guttman-Yassky, Robert Bissonnette, Kim A. Papp, Katrin Holzwarth, Jonathan I. Silverberg, Seth Forman, Matthew J. Zirwas, Jill Waibel, Margaret Gamalo, Jinglin Zhong
Publikováno v:
Journal of the American Academy of Dermatology. 85:62-70
Baricitinib, an oral selective Janus kinase 1/Janus kinase 2 inhibitor, is being studied for moderate-to-severe atopic dermatitis (AD) in adults.To evaluate the efficacy and safety of baricitinib monotherapy in a North American phase 3 trial (BREEZE-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfca1e87145c0ce787cc0723631c6f5
https://doi.org/10.1016/j.jaad.2021.02.028
https://doi.org/10.1016/j.jaad.2021.02.028
Autor:
Peter C Taylor, Tsutomu Takeuchi, Gerd Burmester, Patrick Durez, Josef Smolen, Walter Deberdt, Jinglin Zhong, Jorge Ross Terres, Natalia Bello, Kevin Winthrop
Publikováno v:
Rheumatology. 61
Background/Aims Baricitinib (BARI) is an oral selective Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of adult patients with moderate-to-severe rheumatoid arthritis (RA). Objective Reporting BARI’s safety profile with data up to 9.3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e66d5f4b74d52f0025d156546c5ee4a
https://doi.org/10.1093/rheumatology/keac133.195
https://doi.org/10.1093/rheumatology/keac133.195
Publikováno v:
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics. 39(4)
To explore the genetic basis for a child presented with renal failure and multi-cystic dysplastic kidney without anal atresia.Peripheral blood sample of the child and his parents were collected and subjected to whole exome sequencing. Candidate varia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0033bd3486cafcfb76fa3fc0ab4f4b02
https://pubmed.ncbi.nlm.nih.gov/35446975
https://pubmed.ncbi.nlm.nih.gov/35446975